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Abstract
AIM: To facilitate translational research on cholelithiasis, 
we have developed a rat model of human gallstones 
by exploiting the unique biliopancreatic features of this 
species. 
METHODS: Under anesthesia, 16 adult rats of equal 
genders underwent two times of abdominal surgery. 
First, their common bile duct (CBD) was ligated to 
cause cholestasis by total biliary obstruction (TBO). 
On day 0, 1, 3, 7, 14, 21 and 28 after TBO, magnetic 
resonance imaging (MRI) was conducted to monitor the 
dilatation of the CBD, and blood was sampled to analyze 
total serum bilirubin (TSB). Secondly, on day 30, the 
abdomen was re-opened and gallstone(s) collected from 
human patients were implanted in the dilated CBD as 
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a virtual gallbladder (VGB), which was closed by suture 
ligation. This rat cholelithiasis model was examined by 
MRI, clinical observation, microcholangiography and 
histology.
RESULTS: All rats survived two laparotomies. After 
ligation, the CBD was dilated to a stable size of 4 to 
30 mm in diameter on day 21-28, which became a 
VGB. The rats initially showed signs of jaundice that 
diminished over time, which paralleled with the evolving 
TSB levels from 0.6 ± 0.3 mg/dL before ligation, 
through a peak of 10.9 ± 1.9 mg/dL on day 14, until a 
nearly normalized value after day 28. The dilated CBD 
with thickened wall allowed an incision for implantation 
of human gallstones of 1-10 mm in diameter. The rat 
cholelithiasis was proven by in vivo  MRI and postmortem 
microcholangiography and histomorphology.
CONCLUSION: A rat model cholelithiasis with human 
gallstones has been established, which proves feasible, 
safe, reliable, nontoxic and cost-effective. Given the 
gallstones of human origin, applications of this model 
may be of help in translational research such as optical 
detection and lysis of gallstones by systemic drug 
administration.
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Core tip: The mouse and rat are common experimental 
animals. Unlike the mouse that has a gallbladder but 
difficulty in imaging studies, the rat does not have a 
gallbladder, which has hampered studies on imaging 
gallstones. To tackle this problem, we first induced 
a virtual gallbladder (VGB) in rats by ligation of the 
common bile duct (CBD) accompanying with gradual 
increase and normalization of serum bilirubin. Then we 
implanted gallstone(s) collected from human patients into 
the dilated CBD or VGB to create a cholelithiatic model 
in rats, which has been validated by in vivo  magnetic 
resonance imaging, microcholangiography and histo-
logy. This rat model is deemed useful for translational 
research such as fluorescent visualization of gallstones 
for laparoscopic detection and differential diagnosis of 
cholelithiasis. 
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INTRODUCTION
Cholelithiasis refers to the presence of gallstones that 
are concreted from bile components in the biliary 
tract, usually in the gallbladder. Cholelithiasis is a 
clinical syndrome[1-3] with a global incidence in up to 
20% of the adult population[2,4,5]. The risk factors for 
developing gallstones include gender, age, geographic 
location, genes, ethnicity, metabolic conditions, obesity, 
pregnancy, diet and alcohol or drug consumption[6,7]. 
Cholelithiasis can trigger acute cholecystitis or gall-
bladder inflammation leading to severe abdominal 
pain, jaundice and secondary infections by intestinal 
microorganisms[8,9]. More life-threatening complications 
include acute cholangitis or pancreatitis[10,11]. Stones 
larger than 3 cm or gallbladders packed with stones 
might also increase the risk of gallbladder cancer[6]. 
Over the past decades, research on diagnosis, 
prevention and treatment of cholelithiasis has been 
a popular focus of medical community. By using diffe-
rent methods including gallbladder infection, induced 
biliary stasis, and modified diet[12], animal models of 
cholelithiasis have been created to resemble human 
pathophysiology. However, these models are often cost-
ineffective and unreliable with a low rate of gallstone 
formation or marked hepatotoxicity[12,13]. In addition, 
their gallstone compositions may differ from that in 
humans, making it difficult to extrapolate experimental 
findings to clinic applications. 
Rodents including mice and rats are inexpensive 
and widely applied experimental animals. Rats are 
10-fold bigger in dimension than mice, which eases 
many of the research procedures including noninvasive 
imaging diagnosis using clinical scanners[14]. But, com-
paring to mice, rats lack a gallbladder by nature[12], 
which otherwise would make it impossible to research 
cholelithiasis in this species. However, based on its 
unique biliopancreatic features[15], we hypothesized that 
it could be feasible in the rat first to create a hollow 
biliary organ as a virtual gallbladder (VGB), and then to 
implant human gallstones in it without compromising 
normal bile flow at 22.5 mL/d[16]. To test this hypothesis, 
we conducted two phases of abdominal surgery to ligate 
and dilate the common bile duct (CBD) first and, one 
month later, to implant gallstones in order to create a rat 
model of cholelithiasis. We further validated this model 
by in vivo magnetic resonance imaging (MRI), serial 
blood bilirubin tests, postmortem microcholangiography, 
and histomorphological examinations. Potential 
implications of this rat model of human cholelithiasis for 
translational research include fluorescent visualization 
of gallstones for laparoscopic detection and differential 
diagnosis of gallstones after systemic administration 
of small molecular drugs that undergo hepatobiliary 
excretion as being proven preliminarily[17]. Similarly, new 
litholytic chemicals can be tested this way for therapy.
MATERIALS AND METHODS
Animals
Twenty adult Wistar rats of equal genders weighing 
300-350 g were purchased from Charles River La-
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boratories, Inc. (St. Aubain les Elbeuf, France) and 
housed in environmentally controlled conditions including 
temperature at 23 ℃ ± 2 ℃ and relative humidity at 
60% ± 10% on a 12:12 h light-dark cycle. Standard 
rat chow (Ssniff Spezialdiäten GmbH, Soest, Germany) 
and water were available ad libitum. All experimental 
procedures were approved by the institutional Animal 
Ethics Committee and complied with the European 
Ethics Committee guidelines (decree 86/609/EEC). As 
illustrated in Figure 1, eventually 16 rats were included 
after pilot tests in the first 4 rats.
Creation of a rat model of cholelithiasis 
Ligation of CBD to create a VGB: Under anesthesia 
with intraperitoneal injection of sodium pentobarbital 
(Nembutal; Sanofi Sante Animal, Brussels, Belgium) at 
40 mg per kilogram body weight and after shaving and 
sterilizing the skin, a midline abdominal incision of 4-5 
cm was made through the skin, muscle and peritoneum 
(Figure 2A). The stomach and duodenal loop were 
exposed, and the CBD was identified underneath the 
hepatic hilum. The CBD was ligated adjacent to the 
duodenum[15,18] using a 5-0 silk suture (Ethicon, New 
Jersey, United States). The abdominal wall was closed 
with two layers of consecutive sutures and animals were 
allowed for recovery from anesthesia and surgery. The 
rat model of VGB was thus initiated (Figure 2A-D).
Implantation of human gallstones in the VGB 
to create a cholelithiasis model: Gallstones of 
cholesterol, pigment and mixed contents of 1-10 mm 
in diameter were collected from patients after chole-
cystectomy (Figure 2E). Stones were disinfected by 
immersion in 70% ethanol for 5 min and rinsed with 
sterile physiological saline. Thirty days following CDB 
ligation, under the same anesthetic and laparotomic 
procedures as in the first surgery, the abdomen of CBD-
ligated rats was reopened. The VGB was identified and 
the yellowish bile was aspirated using a syringe with a 
27 gauge needle. The needle hole was extended to a 
length 5 mm by using a pair of microsurgical scissors. 
Depending on the actual size of the VGB and the 
purpose of the study, 1-3 gallstones could be inserted 
into the cavity (Figure 2F-H). The opening was then 
closed with a suture ligation and the animal was left to 
recover from the surgery. 
Assay of total serum bilirubin
For all animals, serum bilirubin was determined on the 
day before of the CDB ligation and on day 1, 3, 7, 14, 
21, 28 and 60 after operation (Figures 1 and 3). Fresh 
blood samples were collected in VACUETTE® heparin 
tubes by cutting a small section of the distal tail with 
a fresh scalpel blade. A droplet of Histoacryl® topical 
adhesive (Braun, Tuttlingen, Germany) was applied on 
the skin incision to stop bleeding. For serum separation, 
the blood samples were allowed to coagulate in the 
dark to prevent enzyme degradation. The samples were 
then centrifuged at 4000 rpm for 10 min at 4 ℃ using 
a 4226 ALC Centrifuge (Milan, Italy). The supernatant 
containing the serum was transferred to 1.5 mL micro-
centrifuge Eppendorf® Safe-Lock® vials. With a Hitachi 
automatic analyzer (Tokyo, Japan), analysis of total 
serum bilirubin (TSB) was carried out.
MRI of the VGB and cholelithiasis 
Before and after each surgical procedure, all rats 
underwent serial MRI scans to monitor the progressive 
expansion of the CBD (Figure 2C and D) and to detect 
the presence of gallstone(s) in the VGB (Figure 2F-H, 
Figure 4A and Figure 5A). Briefly, under gas anesthesia 
using 2% isoflurane (Halocarbon, River Edge, NJ, 
United States) mixed with 20% of O2 and 80% of air, 
MRI was conducted at a clinical 3.0T whole body MR 
magnet (Trio; Siemens, Erlangen, Germany) with a 
maximum gradient capability of 45 mT/m with an 
8-channel phased array wrist coil (in vivo, Latham, NY, 
United States). T2 weighted turbo spin echo images 
were acquired at both transverse and coronal planes of 
1 mm thickness with the following parameters as TR/TE 
= 4300/69 ms, flip angle = 140°, turbo factor = 13, 
field of view = 77 mm × 85 mm, matrix = 414 × 512, 
number of averages = 6 and total imaging time of 3 
min 9 s. 
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Normal rats
(n  = 16)
Day 0 CBD
ligation or TBO
Day 1, 3, 7, 14, 21 
and 28 MRI, TSB and 
μ-cholangiongraphy 
histomorphology 
(n  = 4)
Day 30 
Stone implantation
Day 31-56 
MRI and TSB
Day 60 
μ-cholangiography 
histomorphology 
(n  = 12)
Liver
Stomach
CBD
Virtual gallblader
Gallstone
Figure 1  Flow chart of the experimental procedures. CBD: Common bile 
duct; MRI: Magnetic resonance imaging; TBO: Total biliary obstruction; TSB: 
Total serum bilirubin; μ-cholangiography: Microcholangiography.
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Siemens, Germany) at 26 kV and 15 mA (Figure 4B and 
Figure 5B), followed by fixation in 10% formaldehyde 
for histomorphology (Figure 4C, D and Figure 5C, D). 
RESULTS
General conditions
All 20 rats tolerated well the anesthesia and surgery. 
However, during early pilot stage, 4 rats failed to form 
the final cholelithiasis model, one rat died of cholestasis 
before bile flow recovery, one rat did not show CBD 
dilatation probably due to invalid obstruction because 
of a too distal ligation site, and other two died of 
Postmortem microcholangiography and 
histomorphology
Rats were euthanized by intravenous injection of an 
overdosed Nembutal. The abdomen was opened with 
a skirt incision to expose all abdominal visceral organs 
(Figure 2B). Using a method similar to that reported 
previously[18], the VGB without or with implanted 
gallstone(s) was punctured with a needle-syringe 
to aspirate the bile. Barium sulphate suspension 
(Micropaque; Guerbet, France) was injected to fill in the 
cavity, which was closed by suture ligation. The hepatic, 
biliopancreatic and duodenum were entirely excised 
and digitally radiographed (Mammomat Inspiration; 
June 26, 2016|Volume 6|Issue 2|WJM|www.wjgnet.com
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Figure 2  Creation of a rat model of cholelithiasis. A: Midline abdominal incision for CBD ligation; B: Laparotomy to expose the cholestasis-induced VGB (arrow); 
C: Coronal plane of T2-w MRI displaying an oval-shaped hyperintense dilated CBD or a VGB (arrow); D: Axial plane of T2-w MRI displaying the same oval-shaped 
hyperintense VGB (arrow); E: Gallstones from patients of cholelithiasis derived by cholecystectomy; F: Axial plane of T2-w MRI showing the same case in D but now 
implanted with a human gallstone (arrow); G: Coronal plane of T2-w MRI displaying the same case in F with a gallstone (arrow); H: Coronal plane of T2-w MRI two 
hypointense gallstones (arrows) located in a hyperintense VGB in another case. S denotes stomach on MR images. CBD: Common bile duct; VGB: Virtual gallbladder; 
MRI: Magnetic resonance imaging.
Figure 3  Evolving changes of total serum bilirubin levels in rats after ligation of common bile duct to induce a rat model of virtual gallbladder and 
cholelithiasis. Total bilirubin levels reached the highest values between the days 7 and 14 that and then rapidly dropped to the values close to the normal range after 
day 28 till day 60.
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biliary peritonitis due to the bile leakage after needle 
suture, instead of suture ligation, to close the incision 
after gallstone implantation. Thus, the remaining 16 
rats were included in this study (4 for cholestasis only 
and 12 for cholelithiasis) and sacrificed at designated 
time points for postmortem examinations. No gender 
difference was noticed regarding experimental proce-
dures and outcomes. 
Rat model of VGB 
A VGB was successfully established by ligation of CBD, 
which proved to be safe and was confirmed by in vivo 
June 26, 2016|Volume 6|Issue 2|WJM|www.wjgnet.com
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Figure 5  Magnetic resonance imaging, microcholangiography and histomorphology of a rat on day 60 after surgically induced cholelithiasis. A: Coronal 
T2-w MRI shows a hypointense gallstone located in a hyperintense VGB and distal nondilated CBD as a hyperintense line with L and S denoting the liver and 
stomach; B: Digital microcholangiography displays both the hyperdense VGB and distal nondilated CBD bridged in-between by an pancreatic ductule with P denoting 
the pancreas; C: Macroscopy views the VGB with L denoting the liver, note the distal nondilated and barium-filled CBD imbedded in the pancreas (P) and a branching 
ductule bridging the ligation between the proximal and distal CBD, suggesting resumed bile flow, asterisk indicates where the needle hole was closed by suture 
ligation; D: Photomicrograph of hematoxylin and eosin stained slide of the distal CBD near the ligature (dashed square on B and C) demonstrates multiple proliferated 
glandular ductules (arrows) that contribute to the eventual bypass of the biliary obstruction between the VGB and distal CBD (original magnification × 100). MRI: 
Magnetic resonance imaging; CBD: Common bile duct; VGB: Virtual gallbladder; PD: Pancreatic duct.
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Figure 4  Magnetic resonance imaging, microcholangiography and histomorphology of a rat on day 14 after surgically induced cholestasis towards 
creating a model of virtual gallbladder. A: Coronal T2-w MRI shows an oval-shaped hyperintense dilated CBD or VGB with L, K and S denoting the liver, kidney and 
stomach respectively; B: Digital microcholangiography displays a hyperdense dilated CBD or VGB with L denoting the liver; C: Laparotomic view shows the dilated 
CBD or VGB with L, P and Duo denoting the liver, pancreas and duodenum respectively; note the transparent distal CBD as indicated by a needle tip and an arrow, 
suggesting absent bile flow, and asterisk indicates where the needle hole was closed by suture ligation; D: Photomicrograph of hematoxylin and eosin stained slide 
of the ligature (dashed square on B and C) shows a complete CBD obstruction separating the VGB and distal CBD (original magnification × 100). MRI: Magnetic 
resonance imaging; CBD: Common bile duct; VGB: Virtual gallbladder.
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MRI, normalized total bilirubin, microcholangiography 
and histology (Figures 2-5). The entire procedure 
from induction of anesthesia to closure of skin incision 
took approximately 15 min. During the first 3 wk after 
surgery, the animals showed signs of jaundice including 
yellowish skin and sclera as well as whitish feces, which 
worsened on day 7 to 14 but gradually diminished 
afterwards. The CBD-ligated rats maintained fair life 
quality with normal physical/behavioral manifestations 
without apparent loss of body weight. As shown in 
Table 1, a wide diversity in the dimension of VGB was 
found, ranging from 0.5 to 4.0 cm in diameter and the 
collected bile juice varied from 0.8 to 7.2 mL. 
Rat model of cholelithiasis 
All the 12 rats survived the anesthesia and surgical 
procedures for gallstone implantation in the VGBs. Each 
surgery took about 30 min, somewhat longer than the 
first operation due to intraperitoneal adhesion. After 
VGB isolation and bile aspiration, the gallstone(s) were 
successfully implanted, as seen on MRI (Figure 2F-H 
and Figure 5A). No complications such as bleeding, 
enterocutaneous fistula, infection or sepsis, tissue dam-
age or organ injury were observed. Minimum intra-
abdominal adhesions between the liver and intestinal 
loops near the VGB were encountered, which were 
however manageable by blunt separation maneuver. 
Altogether 20 gallstones varying 1-10 mm in size were 
implanted, i.e., 3, 2 and 1 stone(s) in 2, 4 and 6 rats 
respectively. 
MRI findings 
On coronal and transverse T2-w MRI, 2-3 wk after liga-
tion, a dilated CBD or VGB formed a hyperintense hollow 
organ of pear, circular or cylindrical shapes located 
under the liver at the right upper quadrant region of the 
abdomen, simulating the organ of gallbladder (Figures 
2C, 2D, 4A and 5A). The patent distal CBD was also 
occasionally visible (Figure 5A). T2-w MRI of this rat 
model of cholelithiasis typically displayed hypointense 
gallstone(s) located in a hyperintense dilated CBD or 
VGB (Figure 2F-H and Figure 5A).
Serum biochemical parameters 
Figure 3 depicts the changes of the serum total bilirubin 
concentrations in function of time from CBD-ligated rats 
on the day before the surgery for CDB ligation and on 
day 1, 3, 7, 14, 21, 28 and 60 after operation. Before 
CDB ligation, the total bilirubin values were averaged at 
a normal level of 0.6 ± 0.3 mg/dL. On the successive 
days after surgery, these values increased up to 10.9 ± 
1.9 mg/dL on day 14, but rapidly declined afterwards to 
the level close to the normal range, i.e., 2.2 ± 0.8 mg/dL 
and 1.2 ± 0.4 mg/dL on day 28 and 60, respectively. 
Microcholangiographic findings
On digital microcholangiography, the dilated CBD or 
VGB appeared hyperdense due to the instilled barium 
suspension (Figures 4B and 5B). The 4 rats with hyper-
bilirubinemia or cholestasis sacrificed before day 21 
failed to display the opacified distal CBD (Figure 4B), 
whereas all 12 rats of cholelithiasis displayed both 
the VGB and patent distal CBD due to anastomosis 
formation between biliopancreatic ducts (Figure 5B). 
Histomorphological findings
At autopsy, the dilated CBD appeared as a hollow 
organ filled with the bile that was substituted by barium 
sulphate suspension for microcholangiography, sugge-
stive of a VGB (Figures 4C and 5C). Initially there was 
no bile flow in the distal CBD due to ligation induced 
cholestasis (Figure 4C), but with time the biliary 
obstruction was resolved by collateral formation (Figure 
5C). Microscopically, while the CBD was completely 
obstructed in certain cases (Figure 4D), in other 
cases multiple proliferated biliary ductules could be 
found around the CBD and pancreatic tissue, which 
bypassed the ligation (Figure 5D). These findings 
were consistent with those from MRI (Figure 5A) and 
microcholangiography (Figure 5B).
DISCUSSION 
Cholelithiasis refers to the gallstone formation in the 
biliary tract, usually in the gallbladder. Animal models 
of biliary infection and cholestasis have been applied in 
research for etiology and diagnosis of cholelithiasis as 
well as drug intervention and diet modification for the 
treatment of the disease. These models are often poorly 
manageable, inefficient, expensive, unreliable, and 
hepatotoxic or their applications are hardly translational 
to human scenarios. In the present study, we have 
strived to establish and validate a rat model of human 
gallstones potentially useful in research on cholelithiasis 
or choledocholithiasis especially for developing effective 
diagnostic and therapeutic techniques. This rat model 
of cholelithiasis can be realized by two sequential steps: 
(1) creating a VGB in rats by chronic expansion of the 
CBD into a cystic cavity after CBD ligation; and (2) 
implanting human gallstone(s) in the VGB with resumed 
biliary flow and efficient intestinal discharge, as proven 
by the in vivo MRI findings (Figure 5A), serum bilirubin 
tests (Figure 3), microcholangiography (Figure 5B) 
and histomorphology (Figure 5C and D). Overall, this 
rat model of cholelithiasis turned out to be feasible for 
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No. of rats VGB diameter (cm) Bile volume (mL) Incidence (%)
3 3.1-4.0 7.2 ± 1.9 18.8
6 2.1-3.0 3.8 ± 1.4 37.5
5 1.1-2.0 2.6 ± 1.2 31.3
2 0.5-1.0 0.8 ± 0.3 12.5
Table 1  Magnetic resonance imaging measurements and 
drained bile volumes from rats with cholestasis (n  = 4) and 
cholelithiasis (n  = 12)
VGB: Virtual gallbladder.
Miranda Cona M et al . A rat model of cholelithiasis
160
preparations and reliable for validation. Recently a novel 
optical imaging agent for diagnosis and differential 
diagnosis of human gallstones has been identified by 
using this animal model (paper submitted). 
Unlike experimental gallstone models in the previous 
studies conducted on gallbladder-bearing species such 
as ground squirrels[19], mice[20], dogs, cats, guinea pigs, 
rabbits, sheep, pigs and cattle[12], our experiments 
were conducted on rats that lack a gallbladder. The rat 
specie was chosen due to its amplest availability, lowest 
cost, easiest housing and handling, in addition to its 
feasibility of being imaged by using clinical scanners[14]. 
However, because of its natural deficiency[12], a stru-
cture resembling a gallbladder in both morphology and 
functionality with rats deems mandatory to further study 
cholelithiasis. In concordance with previous studies[17,21], 
after ligation the proximal CBD increased its diameter 
with a noticeably thickened wall due to the evolving bile 
stasis. Studies showed that the diameters of the CBD 
could enlarge from 0.3 to 8 mm in only 5 d owing to bile 
accumulation[21], and further dilate to a few centimeters 
in 2-3 wk[18]. This can explain the dimensions up to 40 
mm of the VGB with a large volume of bile collected in 
our model rats 4 wk after CBD ligation. 
A recovery period of four weeks was chosen, 
because shortly after surgery the rats showed limited 
activity with weak mechanical strength of the CBD. 
In animals, persistent obstruction of CBD may cause 
cholestatic liver injury, hyperbilirubinemia, portal 
hypertension, ascites, endocrine disorders, hepatic 
encephalopathy and skeletal fragility (osteopenia)[22-24]. 
Interestingly, especially in rats, after a course of about 
4 wk of CBD obstruction, they progressively recovered 
from cholestasis with a diminishing serum bilirubin 
level, improved jaundice symptoms, and gain in body 
weight and strength. This recovery response could 
be explained by the unique proliferative changes of 
the biliopancreatic duct tree after a complete CDB-
ligation in rats[18,25]. Contrary to humans, in which 
complete biliary obstruction can be life threatening[26], 
most of such cholestatic rats eventually survived due 
to formation of sufficient biliary collaterals, which has 
been widely referred in the literature[18,25,27]. Indeed, 
the CDB-ligated rats have been used as a model of 
typical and selective cholangiocytic proliferation, which 
is characterized by an increased biliary pressure that 
triggers newly formed capillary networks or peribiliary 
capillary plexuses surrounding the intrahepatic bile duct 
branches over time[27,28]. It seems that native bile ducts, 
the preexisting bile capillary and proliferated ductules 
jointly play a significant role in the transport mechanism 
of biliary substances, secretion and reabsorption of 
water and electrolytes[29]. Therefore, this phenomenon 
might explain the recovery of the CBD-ligated rats 
during thirty days after a complete CBD obstruction 
in rats. Moreover, a period of thirty days also allowed 
the natural absorption of the intra-abdominal fibrous 
adhesion caused by the first CBD-ligation surgery. As 
a consequence, during the second surgery for stone 
implantation, the exposure of and access to the newly 
formed VGB became easier with less complications. 
Furthermore, during this elongated period, the thick-
ened “gallbladder” wall due to tissue proliferation 
eased incision and closure for stone implantation and 
prevention of bile leakage. 
The second step for preparing the rat model of 
cholelithiasis is to embed human gallstone(s) into the 
VGB of rats 4 wk after CBD-ligation. Human gallstones 
were categorized into 3 common types as cholesterol, 
pigment and mixed stones[30]. Therefore, the rat 
cholelithiasis model introduced here would be suitable in 
studies on diagnostic or therapeutic interventions with 
chemical drugs that could undergo the bile excretion 
and further interact with a particular component of the 
stone from human patients as exemplified in our recent 
study[17]. 
By direct implantation of human gallstones, we 
intended to overcome the limitations with the previous 
models of gallstone disease such as gallbladder infe-
ction, production of biliary stasis, and diet composition 
modifications[12]. Gallbladder concretions were gene-
rated in rabbits subjected to infection with different 
bacteria such as coliform, vibrio cholera, typhoid bacilli, 
and streptococci isolated from tonsils and human 
gallbladders[12,31]. Biliary stasis based on CBD ligation 
in combination with bacteria inoculation resulted in 
more reliable formation of gallstone than bacterial 
injection alone[32]. Gallbladder trauma along with 
bacterial infection has been also proved to be effective 
to cause gallstones[33]. However, these bacterial methods 
generally require serial inoculations and longer time. 
In the case of the bile stasis methods, they could be 
unreliable and inconsistent. The gallstone production 
by dietary modifications appeared successful with 
numerous dietary schemes including cholesterol and 
sunflower seed oil in rabbits[12], cholesterol rich foods[34], 
diet rich in sucrose (74.3%) with low lipid content 
in hamsters[35], and ground chow either with 1% 
cholesterol or 0.5% cholic acid in mice[36]. However, the 
dietary methods were frequently hepatotoxic and some 
animals poorly tolerated the diet, and the models were 
time consuming and inconsistent[12]. The most rapid and 
reliable system seemed to be the dihydrocholesterol-
rabbit model leading to cholelithiasis within fifteen 
days without apparent toxicity in the liver. However, 
the gallstone composition was dissimilar to that in 
humans, thus not translational for many applications. 
The formation of human-type gallstones by feeding 
guinea pigs with modocoll and cholestyramine was also 
tried with satisfactory frequency and quickness without 
hepatotoxicity[12], which however was more expensive 
than other small rodent models[13]. 
There exist advantages and disadvantages or 
limitations with this cholelithiasis model in rats. First, 
the model was not intended for studying the formation 
or etiology of gallstones, instead it is for validating 
diagnostic or therapeutic agents potentially interactive 
with human gallstones after systemically administration, 
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hepatic uptake or metabolism and biliary excretion. 
Second, the model appears complex to make, but 
all rats tolerated the twice surgical procedures with 
a high success rate. Third, indeed the ligation of the 
CBD induced cholestatic liver injury, cholangiocellular 
proliferation, ductular reaction and fibrosis up to the 
development of biliary cirrhosis from seven days to 
weeks after surgery. But, in rodents bile flow does 
resume with time as proven by gradually normalized 
serum hepatic enzymatic parameters[18], which closely 
simulates cholelithiatic patients with chronic and repe-
ated onset of cholestasis. Thus, this rat model of human 
gallstones with background histological alterations could 
be suitable for certain clinically relevant translational 
research[17]. 
Technically, the high success rate of this model was 
assured by two major factors. First, the cholestasis 
induced by CBD ligation in rats is only transient as 
evidenced by normalization of serum bilirubin level and 
resumed bile flow seen on micro-cholangiography[18]. 
Secondly, after implantation of human gallstones, careful 
closure of VGB wall proved crucial to avoid any bile 
leakage that is a lethal complication.
In conclusion, we have introduced a rat model of 
cholelithiasis with human gallstones, which appears 
to be an experimental model with certain desirable 
characteristics[12]. It is a relatively simple and cost-
effective method that offers the possibility of studying 
already formed human gallstones in rats. It was not 
toxic since no special diet different to the standard 
rodent chow is required. Another practical aspect is the 
time consumed for the model of gallstones. In contrast 
to previous reports in which the formation can occur 
in up to a year[12], the proposed animal model can be 
invariably ready by around sixty days. Most importantly 
it may offer translational results for clinically relevant 
applications since it contains human gallstones. 
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